You are here

  • Home
  • Archive
  • Volume 9, Issue 8
  • Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I–III small cell lung cancer

Article metrics

Article menu
XML
Basic tumor immunology
Original research
Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I–III small cell lung cancer

 

Online download statistics by month:

Online download statistics by month: August 2021 to March 2026

AbstractFullPdf
Aug 2021549547265
Sep 202120320473
Oct 202113313348
Nov 202112612751
Dec 2021858522
Jan 2022686938
Feb 2022464725
Mar 2022626329
Apr 2022565727
May 2022494927
Jun 2022565919
Jul 2022555747
Aug 2022666624
Sep 2022767617
Oct 2022646520
Nov 2022384025
Dec 2022323225
Jan 2023454518
Feb 2023626220
Mar 2023313519
Apr 2023293118
May 202324248
Jun 2023212119
Jul 2023242418
Aug 2023273021
Sep 2023424333
Oct 2023262625
Nov 2023424223
Dec 2023474724
Jan 2024313318
Feb 2024303023
Mar 2024383826
Apr 2024272823
May 2024353627
Jun 2024393927
Jul 2024484925
Aug 2024353267
Sep 2024242417
Oct 20243434200
Nov 2024373916
Dec 2024585923
Jan 2025535324
Feb 202513813814
Mar 2025626229
Apr 2025838328
May 2025444423
Jun 2025343517
Jul 2025110
Mar 2026110
Total303630641655